Secondary osteoporosis: Thyrotoxicosis, rheumatoid arthritis, and diabetes mellitus

Journal of Bone and Mineral Metabolism

Volumn 22, Issue 4, 2004, Pages 287-292

  Inaba, Masaaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes mellitus; Glucocorticoid; Hyperparathyroidism; Osteoporosis; Rheumatoid arthritis; Thyrotoxicosis

Indexed keywords

GLUCOCORTICOID;

BONE DISEASE; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM METABOLISM; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERPARATHYROIDISM; INSULIN DEFICIENCY; INTESTINE ABSORPTION; OSTEOBLAST; OSTEOPENIA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SECONDARY OSTEOPOROSIS; THYROTOXICOSIS;

EID: 3242779510     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-004-0501-7     Document Type: Review

References (53)

1. Britto JM, Fenton AJ, Holloway WR, Nicholson GC (1992) Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 134:327-331
2. Kim CH, Kim HK, Shong YK, Lee KU, Kim GS (1999) Thyroid hormone stimulates basal and interleukin (IL)-1-induced IL-6 production in human bone marrow stromal cells: a possible mediator of thyroid hormone-induced bone loss. J. Endocrinol 160:97-102
3. Allain TJ, McGregor AM (1993) Thyroid hormones and bone. J Endocrinol 139:9-18
4. Riggs BL, Melton LJ III (1986) Involutional osteoporosis. N Engl J Med 314:1676-1686
5. Abu EO, Horner A, Teti A, Chatterjee VK, Compston JE (2000) The localization of thyroid hormone receptor mRNA in human bone. Thyroid 10:287-293
6. Jódar E, Muñoz-Torres M, Escobar-Jiménez F, Quesada-Charneco M, Luna del Castillo JD (1997) Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause. Clin Endocrinol (Oxf) 47:279-285
7. Nagasaka S, Sugimoto H, Nakamura T, Kusaka I, Fujisawa G, Sakuma N, Tsuboi Y, Fukuda S, Honda K, Okada K, Ishikawa S, Saito T (1997) Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis. Clin Endocrinol (Oxf) 47:215-221
8. Shafer RB, Gregory DH (1972) Calcium malabsorption in hyperthyroidism. Gastroenterology 63:235-239
9. Epstein FH, Freedman LR, Levitin H (1958) Hypercalcemia, nephrocalcinosis and reversible renal insufficiency associated with hyperthyroidism. N Engl J Med 259:782-788
10. Inaba M, Hamada N, Ito K, Mimura T, Ohno M, Yamakawa J, Ikeda S, Okamoto T, Morii H (1982) A case report on disequilibrium hypercalcemia in hyperthyroidism. Endocrinol Jpn 29:389-393
11. Jodar E, Muñoz-Torres M, Escobar-Jiménez F, Quesada-Charneco M, Luna del Castillo JD (1997) Bone loss in hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause. Clin Endocrinol (Oxf). 47:279-285
12. Langdahl BL, Loft AGR, Eriksen EF, Mosekilde L, Charles P (1996) Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 6:161-168
13. Muddle AH, Houben AJ, Nieuwenhuijzen Kruseman AC (1994) Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol (Oxf) 41:421-424
14. Kasagi K, Takeuchi R, Misaki T, Kousaka T, Miyamoto S, Iida, Y, Konishi J (1997) Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects. J Endocrinol Invest 20:183-188
15. Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y (2000) Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. J Clin Endocrinol Metab 85:4157-4167
16. Inoue M, Tawata M, Yokomori N, Endo T, Onaya T (1998) Expression of thyrotropin receptor on clonal osteoblast-like rat osteosarcoma cells. Thyroid 8:1059-1064
17. Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M (2003) TSH is a negative regulator of skeletal remodeling. Cell 17:151-162
18. Tsai JA, Janson A, Bucht E, Kindmark H, Marcus C, Stark A, Zemack HR, Torring O (2004) Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells. Calcif Tissue Int (in press)
19. Lupoli G, Nuzzo V, Di Carlo C, Affinito P, Vollery M, Vitale G, Cascone E, Arlotta F, Nappi C (1996) Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole. Gynecol Endocrinol 10:343-348
20. Kung AW, Ng F (1994) A rat model of thyroid hormone-induced bone loss: effect of antiresorptive agents on regional bone density and osteocalcin gene expression. Thyroid 4:93-98
21. Faber J, Galloe AM (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130:350-356
22. Duncan WE, Chung A, Solomon B, Wartofsky L (1994) Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone. Thyroid 4:183-190
23. Meier C, Beat M, Guglielmetti M, Christ-Grain M, Staub JJ, Kraenzlin M (2004) Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial. Osteoporos Int 15:209-216
24. Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H, Sugiguchi S, Fujiwara S, Emoto M, Ishimura E, Onoda N, Ishikawa T, Nishizawa Y (2003) Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin Endocrinol (Oxf) 59:607-612
25. Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H, Ishimura E, Onoda N, Ishikawa T, Nishizawa Y (2004) Change in von Willebrand factor and carotid intima-media thickness in hypothyroid patients with normal thyroid function after levothyroxine replacement therapy. Eur J Endocrinol 150:125-131
26. Deodhar AA, Woolf AD (1996) Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35:309-322
27. Inaba M, Nagata M, Goto H, Kumeda Y, Kobayashi K, Nakatsuka K, Miki T, Yamada S, Ishimura E, Nishizawa Y (2003) Preferential reductions of paraarticular trabecular bone component in ultradistal radius and of calcaneus on ultrasonography in early-stage rheumatoid arthritis. Osteoporos Int 14:683-687
28. Furumitsu Y, Inaba M, Yukioka K, Yukioka M, Kumeda, Y, Azuma Y, Ohta T, Ochi T, Nishizawa Y, Morii H (2000) Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis. J Rheumatol 27:64-70
29. Chu CQ, Filed M, Allard S, Abney E, Feldmann M, Maini RN (1992) Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis; implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 32:653-661
30. Inaba M, Yukioka K, Furumitsu Y, Murano M, Goto H, Nishizawa Y, Morii H (1997) Positive correlation between levels of IL-1 or IL-2 and 1,25(OH)2D/25-OH-D ratio in SF of patients with rheumatoid arthritis. Life Sci 61:977-985
31. Sambrook PN, Reeve J (1988) Bone disease in rheumatoid arthritis. Clin Sci 74:225-230
32. Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, Ishimura E, Inui K, Yutani Y, Miki T, Shoji T, Nishizawa Y (2002) Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis Arthritis Rheum 46:1489-1497
33. Nagata-Sakurai M, Inaba M, Goto H, Kumeda Y, Furumitsu Y, Inui K, Koyama H, Emoto M, Ishimura E, Shoji T, Nishizawa Y (2003) Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 48:3061-3067
34. Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B (1998) Is bone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol 25:1251-1253
35. Sambrook PN, Spector TD, Seeman E, Bellamy N, Buchanan RR, Duffy DL, Martin NG, Prince R, Owen E, Silman AJ (1995) Osteoporosis in rhematoid arthritis: a monozygotic co-twin control study. Arthritis Rheum 38:806-809
36. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper (1997) Effect of low does methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 24:1489-1494
37. Inaba M, Morii H, Katsumata T, Goto H, Ishimura E, Kawagishi T, Kamao M, Okano T, Nishizawa Y (2000) Hyperparathyroidism is augmented by ovariectomy in Nagase analbuminemic rats. J Nutr 130:1543-1547
38. Schneider LE, Schedl HP (1972) Diabetes and intestinal calcium absorption in the rat. Am J Physiol 223:1319-1323
39. Leman J Jr, Lennon EJ, Piering WR, Prien EL Jr, Ricinati ES (1970) Evidence that glucose ingestion inhibits net renal tubular reabsorption of calcium and magnesium in man. J Lab Clin Med 75:578-585
40. Imura H, Seino Y, Nakagawa S, Goto Y, Kosaka K, Sakamoto N (1987) Diabetic osteopenia in Japanese: a geographic study. J Jpn Diabetes Soc 30:9924-9929
41. Klein M, Frost HM (1964) The numbers of bone resorption and formation in rib. Henry Ford Hosp Med Bull 12:527-536
42. Rico H, Hernandez ER, Cabranes JA, Gomez-Castresana F (1989) Suggestion of a deficient osteoblastic function in diabetes mellitus: the possible cause of osteopenia in diabetics. Calcif Tissue Int 45:71-73
43. Ishida H, Seino Y, Taminato T, Usami M, Takeshita N, Seino Y, Tsutsumi C, Moriuchi S, Akiyama Y, Hara K, et al. (1988) Circulating levels and bone contents of bone γ-carboxyglutamic acid-containing protein are decreased in streptozotocin-induced diabetes: possible marker of diabetic osteopenia. Diabetes 37: 702-706
44. Wettenhall REH, Schwqarz PL, Bornstein J (1969) Actions of insulin and growth hormone on collagen and chondroitin sulfate synthesis in bone organ cultures. Diabetes 18:280-284
45. Inaba M, Terada M, Koyama H, Yoshida O, Ishimura E, Kawagishi T, Okuno Y, Nishizawa Y, Otani S, Morii H (1995) Influence of high glucose on 1,25-dihydroxy vitamin D3-induced effect on human osteoblast-like MG-63 cells J Bone Miner Res 10:1050-1060
46. Terada M, Inaba M, Yano Y, Hasuma, T, Nishizawa Y, Morii H, Otani S (1988) Growth-inhibithory effect of a high glucose concentration on osteoblast-like cells. Bone 22:17-23
47. Inaba M, Terada M, Nishizawa Y, Shioi A, Ishimura E, Otani S, Morri H (1999) Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism. Metabolism 48:904-909
48. Inaba M, Nishizawa Y, Mita K, Kumeda Y, Emoto M, Kawagishi T, Ishimura E, Nakatsuka K, Shioi A, Morii H (1999) Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int 9:525-531
49. Inaba M, Nishizawa Y, Shioi A, Morii H (1997) Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway. Osteoporos Int 7 (Suppl 3):S209-S212
50. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM (1995) Bone loss and bone turnover in diabetes. Diabetes 44:775-782
51. Scwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cumming SR (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32-38
52. Chung YS, Lee MD, Lee SK, Kim HM, Fitzpatrick LA (2000) HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 85:41137-1142
53. Wada Y, Nakamura Y, Koshiyama H (2000) Lack of positive correlation between statin use and bone mineral density in Japanese subjects with type 2 diabetes. Arch Intern Med 160:2865